Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trace-Ability is a medical technology company that specializes in automating the quality control (QC) of radiopharmaceuticals used in PET and SPECT imaging. The company's core technology, Tracer-QC, replaces traditional, manual, and labor-intensive testing methods with a streamlined, automated process that utilizes optical sensors and pre-packaged reagent kits. This innovation significantly reduces the risk of human error, minimizes radiation exposure for laboratory personnel, and accelerates the release of short-lived diagnostic tracers to patients. By providing a standardized and compliant testing platform, Trace-Ability helps radiopharmacies and clinical centers improve operational efficiency and maintain rigorous safety standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trace-Ability.